CAR T Cells Show Activity in Solid Tumors
Gastric cancer patients in a trial responded to a CAR-T therapy targeting a molecule found in epithelial cells called claudin 18.2. Additional... Read More
Updated Clinical Data from Combination of Margetuximab and Pembrolizumab in Gastric Cancer Presented at 2019 ASCO Gastrointestinal Cancers Symposium
“We continue to be very encouraged by the tolerability and antitumor activity of margetuximab with an anti-PD-1 mAb, an investigational, chemotherapy-free approach... Read More
Clinicopathological significance of RCAN2 production in gastric carcinoma
Researchers examined calcineurin 2 (RCAN2) regulators and expression patters, finding RCAN2 is correlated with tumor progression and an independent prognostic classifier for... Read More
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
Research in its very early stages uses engineered immune cells (CAR-T) to target gastric cancer tumors.
Clinicopathologic features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction
A small study looks into features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction. They found metastatic... Read More
